During the past decade, Gastroenterologie Eppendorfer Baum conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Gastroenterologie Eppendorfer Baum" are "Ulcerative Colitis" (3 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Gastroenterologie Eppendorfer Baum" in a lesser frequency.

Most popular intervention types in "Gastroenterologie Eppendorfer Baum" are "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Etrolizumab" (2 trials), "Conventional Step-care Algorithm" (1 trials), "Enhanced Treatment Algorithm" (1 trials), "Etrozulimab" (1 trials) and "Infliximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gastroenterologie Eppendorfer Baum" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Gastroenterologie Eppendorfer Baum". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Gastroenterologie Eppendorfer Baum, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gastroenterologie Eppendorfer Baum, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".